Get regular updates to your inbox.
Cannabis, otherwise known as marijuana, may be recommended as an add-on therapy for MS patients. One such treatment being investigated is Sativex, an oral spray that contains cannabis extracts, to improve spasticity in MS patients.
Sativex (nabiximols), an oral spray that contains cannabis extracts, was found effective as an add-on therapy for easing spasticity in adult multiple sclerosis (MS) patients who failed to respond to other anti-spastic treatments, a real-world study from Belgium reports. Overall,…
Read moreWelsh health minister Mark Drakeford has announced that Wales has become the first UK country to authorize a cannabis-based medicine under its National Health Service. Sativex, a proprietary oral spray cannabinoid medicine that has been licensed…
The Republic of Ireland is legalizing the medical prescription of cannabis for people with Multiple Sclerosis, under a new revision to current Irish laws. The Irish Mirror reports that Pat O’Mahony, CEO of Ireland’s Health Products Regulatory…
Steve Pepple / Shutterstock.com The 2012 state ballot approvals of marijuana legalization in Colorado and Washington has been a catalyst for stirring the pot, so to speak, on a wide range of issues and…
Marijuana has been approved for medicinal purposes in a number of U.S. states, however it still remains a much debated issue according to the American Academy of Neurology. New information has been released by ANN Annual Meeting in…
We consulted some of our community contributors at MS News Today and came up with 12 questions people should consider asking their doctors after an MS diagnosis.
Check it out by clicking here.
Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.
Get regular updates to your inbox.